Detalles de la búsqueda
1.
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Am J Gastroenterol
; 118(8): 1373-1380, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728217
2.
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
Ann Hematol
; 102(8): 2233-2240, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392367
3.
Clinical Impact of Extranodal Metabolic Tumor Volume in 240 Diffuse Large B cell Lymphoma Patients with Extranodal Involvement.
Ann Hematol
; 100(5): 1221-1229, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33768337
4.
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
Ann Hematol
; 99(2): 309-319, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872360
5.
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
Am J Hematol
; 95(4): 413-421, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31919872
6.
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
Acta Haematol
; 140(3): 146-156, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253397
7.
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Biol Blood Marrow Transplant
; 23(9): 1555-1566, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28552421
8.
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Blood
; 126(6): 746-56, 2015 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26065651
9.
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.
Ann Hematol
; 96(11): 1801-1809, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28828639
10.
Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy.
Ann Hematol
; 96(1): 17-23, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27677489
11.
Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload.
Transfusion
; 55(7): 1613-20, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25764017
12.
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 90(11): 1013-20, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26228525
13.
Severe Liver Dysfunction after Donor Lymphocyte Infusion for Relapsed Multiple Myeloma.
Korean J Gastroenterol
; 83(3): 123-126, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38522856
14.
Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study.
Clin Lymphoma Myeloma Leuk
; 24(2): e50-e57.e2, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37973459
15.
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea.
Cancer Res Treat
; 56(2): 681-687, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946408
16.
Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913).
Cancer Res Treat
; 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453275
17.
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.
Nat Commun
; 15(1): 2776, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555311
18.
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials.
Leuk Res
; 143: 107542, 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38924942
19.
Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Int J Cancer
; 133(3): 645-52, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23354517
20.
Locally recurrent penile apocrine carcinoma initially diagnosed as metastatic adenocarcinoma of colon.
Chin J Cancer Res
; 25(6): 777-80, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24385708